Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Current and emerging molecular and epigenetic disease entities in acute myeloid leukemia and a critical assessment of their therapeutic modalities

23 Nov 2020

Abstract excerpt

No abstract is available from the source.

Topics

Join the communities discussing this publication.

Acute Myeloid Leukemia Research
Histone Deacetylase Inhibitors Research
Protein Degradation and Inhibitors

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33242577
DOI: 10.1016/j.semcancer.2020.11.010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Current and emerging molecular and epigenetic disease entities in acute myeloid leukemia and a critical assessment of their therapeutic modalitiesPMID 33242577Read ↗

Recent advances in the understanding and treatment of acute myeloid leukemiaSemantic proximity Read ↗

Toward Individualized Therapy in Acute Myeloid Leukemia: A Contemporary Review.Semantic proximity Read ↗

The evolving landscape of epigenetic target molecules and therapies in myeloid cancers: focus on acute myeloid leukemia and myeloproliferative neoplasmsSemantic proximity Read ↗

Epigenetic Modifications in Acute Myeloid Leukemia: Prognosis, Treatment, and HeterogeneitySemantic proximity Read ↗

Advances in acute myeloid leukemia.Semantic proximity Read ↗

Epigenetics in Hematological Malignancies.Semantic proximity Read ↗

Clinical developments in epigenetic-directed therapies in acute myeloid leukemiaSemantic proximity Read ↗

Genetic and epigenetic map of acute myeloid leukemia.Semantic proximity Read ↗

Epigenetic regulators as promising therapeutic targets in acute myeloid leukemiaSemantic proximity Read ↗

Epigenetic alterations in acute myeloid leukemiasSemantic proximity Read ↗

‘Acute myeloid leukemia: a comprehensive review and 2016 update’Semantic proximity Read ↗

Chronic Myeloid Leukemia: Current Application of Cytogenetics and Molecular Testing for Diagnosis and TreatmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.